AI assistant
Sending…
Alector, Inc. — Director's Dealing 2019
Nov 8, 2019
33290_dirs_2019-11-08_b48a8168-ca1f-41b8-8f3c-b118de337bd8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Alector, Inc. (ALEC)
CIK: 0001653087
Period of Report: 2019-11-06
Reporting Person: Paul Robert (Chief Medical Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-06 | Stock Option (right to buy) | $17.15 | A | 150000 | Acquired | 2029-11-05 | Common Stock (150000) | Direct |
Footnotes
F1: One forty-eighth (1/48th) of the shares subject to the option shall vest on the one month anniversary of November 6, 2019 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the shares shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to have a Service Relationship (as defined in the Issuer's 2019 Equity Incentive Plan) with the Issuer through each such date.
More from Alector, Inc.
Regulatory Filings
2026
May 7
Capital/Financing Update
2026
May 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 26
Annual Report
2026
Feb 25
Earnings Release
2026
Feb 25